Methylphenidate for fatigue in ambulatory men with prostate cancer
Open Access
Abstract
BACKGROUND: Fatigue is a highly prevalent and clinically significant symptom of advanced prostate cancer. To date, however, there are no published controlled trials of interventions for fatigue in men with prostate cancer. METHODS: This 6‐week, randomized, double‐blind, placebo‐controlled design evaluated the efficacy of methylphenidate to treat fatigue in prostate cancer patients. Inclusion criteria included men with advanced prostate cancer and the presence of moderate to severe fatigue. Patients with major depression, hypothyroidism, uncontrolled hypertension, arrhythmia, or anemia were excluded. Fatigue levels, blood pressure, pulse, and other safety concerns were monitored regularly. RESULTS: Thirty‐two subjects were randomized to methylphenidate (n = 16) or placebo (n = 16). Brief Fatigue Inventory total scores significantly decreased for both groups; however, the methylphenidate group, as compared with placebo, reported greater decrease on Brief Fatigue Inventory severity scores (P = .03) and a trend toward greater decrease on Brief Fatigue Inventory total scores (P = .07). A significantly greater number of subjects in the methylphenidate group versus the placebo group demonstrated clinically significant improvement in fatigue on total Brief Fatigue Inventory scores (7 of 10 vs 3 of 13) and Brief Fatigue Inventory severity scores (8 of 10 vs 3 of 13). Importantly, 6 subjects in the methylphenidate group discontinued because of increased blood pressure or tachycardia. There were no serious adverse events. CONCLUSIONS: Methylphenidate is effective in treating fatigue in men with prostate cancer; however, oncologists need to monitor for possible pulse and blood pressure elevations. Cancer 2010. © 2010 American Cancer Society.Keywords
This publication has 58 references indexed in Scilit:
- Efficacy of Dexmethylphenidate for the Treatment of Fatigue After Cancer Chemotherapy: A Randomized Clinical TrialJournal of Pain and Symptom Management, 2009
- A Pilot Study Evaluating the Safety and Efficacy of Modafinil for Cancer-Related FatigueJournal of Palliative Medicine, 2009
- Randomized Controlled Trial of Resistance or Aerobic Exercise in Men Receiving Radiation Therapy for Prostate CancerJournal of Clinical Oncology, 2009
- Methods to Explain the Clinical Significance of Health Status MeasuresMayo Clinic Proceedings, 2002
- Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot studyAmerican Journal of Hospice and Palliative Medicine®, 2001
- The Treatment of Advanced Prostate Cancer with KetoconazoleDrug Safety, 1999
- The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distressEuropean Journal of Cancer, 1994
- General Versus Systematic Inquiry about Emergent Clinical Events with SAFTEEJournal of Clinical Psychopharmacology, 1992
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- Use of psychostimulants in medically ill depressed patientsPsychosomatics, 1982